Submitted by Anonymous (not verified) on 5 February 2026 - 9:30
Human medicines European public assessment report (EPAR): Prevenar 13, pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed), Date of authorisation: 09/12/2009, Revision: 50, Status: Authorised
Source: